Goodwill is recorded when the consideration paid for a business combination exceeds the fair value of net tangible and identifiable intangible assets acquired. The Company tests its goodwill balances for impairment annually as of the beginning of the second quarter or more frequently if indicators are present or changes in circumstances suggest that an impairment may exist. The Company performed the most recent annual goodwill and indefinite-lived intangible asset impairment test as of the beginning of the second quarter of 2025 and noted no impairment.

Goodwill by reportable segment as of April 3, 2026 was as follows (in thousands):


	Reportable Segment
	Automation Enabling Technologies			Medical Solutions			Total
Goodwill	$	445,984		$	348,624		$	794,608
Accumulated impairment of goodwill		(119,507	)		(31,722	)		(151,229	)
Total	$	326,477		$	316,902		$	643,379

Goodwill by reportable segment as of December 31, 2025 was as follows (in thousands):


	Reportable Segment
	Automation Enabling Technologies			Medical Solutions			Total
Goodwill	$	447,313		$	351,264		$	798,577
Accumulated impairment of goodwill		(119,507	)		(31,722	)		(151,229	)
Total	$	327,806		$	319,542		$	647,348

Intangible assets as of April 3, 2026 and December 31, 2025, respectively, are summarized as follows (in thousands):


	April 3, 2026							December 31, 2025
	Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization			Net Carrying Amount
Amortizable intangible assets:
Patents and developed technologies	$	234,440	$	(183,440	)	$	51,000	$	235,851	$	(180,798	)	$	55,053
Customer relationships		294,946		(195,209	)		99,737		296,868		(191,037	)		105,831
Trademarks and trade names		25,095		(18,560	)		6,535		25,261		(18,396	)		6,865
Amortizable intangible assets		554,481		(397,209	)		157,272		557,980		(390,231	)		167,749
Non-amortizable intangible assets:
Trade names		13,027		—			13,027		13,027		—			13,027
Total intangible assets	$	567,508	$	(397,209	)	$	170,299	$	571,007	$	(390,231	)	$	180,776

All definite-lived intangible assets are amortized either on a straight-line basis or an economic benefit basis over their remaining estimated useful life. Amortization expense for patents and developed technologies is included in cost of revenue in the accompanying consolidated statements of operations. Amortization expense for customer relationships and definite-lived trademarks, trade names and other intangibles is included in operating expenses in the accompanying consolidated statements of operations. Amortization expense was as follows (in thousands):


	Three Months Ended
	April 3,		March 28,
	2026		2025
Amortization expense – cost of revenue	$	3,759	$	3,561
Amortization expense – operating expenses		5,774		5,554
Total amortization expense	$	9,533	$	9,115

As of April 3, 2026, estimated amortization expense for each of the five succeeding years and thereafter was as follows (in thousands):


Year Ending December 31,	Cost of Revenue		Operating Expenses		Total
2026 (remainder of year)	$	11,231	$	17,225	$	28,456
2027		12,064		19,132		31,196
2028		10,263		16,100		26,363
2029		7,398		12,527		19,925
2030		4,728		10,059		14,787
Thereafter		5,316		31,229		36,545
Total	$	51,000	$	106,272	$	157,272